Latest News about TCRR
Recent news which mentions TCRR
TCR2 Therapeutics Shares Jump After Additional Reponses in Ovarian Cancer, Mesothelioma
September 28, 2022
Tickers
TCRR
From Benzinga
From InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 27, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
May 26, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 19, 2022
From Benzinga
10 Biggest Price Target Changes For Wednesday
March 23, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 22, 2022
From Benzinga
43 Stocks Moving In Tuesday's Mid-Day Session
March 22, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
March 14, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 22, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 18, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 17, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 25, 2022
From Benzinga
20 Stocks Moving in Tuesday's Pre-Market Session
January 25, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 21, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 20, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 19, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
January 14, 2022
From Benzinga
10 Biggest Price Target Changes For Thursday
January 13, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 06, 2022
From Benzinga
10 Biggest Price Target Changes For Thursday
October 21, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 20, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 14, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
|
|
|
|
|
|